May 12, 2026 05:30PM
May 12, 2026 04:02PM
May 12, 2026 04:02PM
Mar 26, 2026 04:02PM
Nov 13, 2025 05:05PM
Nov 12, 2025 04:05PM
Aug 12, 2025 06:06PM Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 5c
Aug 12, 2025 04:02PM
May 14, 2025 05:21PM
May 13, 2025 04:02PM
Apr 17, 2025 07:38AM
Apr 3, 2025 06:46AM
Mar 27, 2025 04:02PM
Mar 18, 2025 04:48PM Notice to Long-Term Shareholders of Archer-Daniels-Midland Co. (NYSE: ADM); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Kyverna Therapeutics, Inc. (Nasdaq: KYTX); and Mercury Systems, Inc. (Nasdaq: M
Mar 17, 2025 03:01PM
Mar 13, 2025 06:21PM
Nov 20, 2024 06:46AM
Nov 13, 2024 04:14PM
Aug 12, 2024 04:08PM
May 14, 2024 04:05PM
Mar 26, 2024 04:05PM Kyverna Therapeutics Provides Business Update and Reports Full Year 2023 Financial Results

1,199,636 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All